1st Quarter - Report — ALLERGAN USA, INC. for ALLERGAN USA, INC. (2008)

Firm

ALLERGAN USA, INC.

Client

ALLERGAN USA, INC.

Income

—

Expenses

$295,390

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R. 1908, S. 1145 Patent Reform Act of 2007 H.R. 806 To Amend the Food, Drug, and Cosmetic Act to Prohibit the Marketing of Authorized Generics S. 438 Fair Prescription Drug Competition Act H.R. 1038, S. 623 Access to Life Saving Medicines Act H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 Pathway for Biosimilars Act

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 806 (110th), S. 1145 (110th), H.R. 1908 (110th), H.R. 1956 (110th), S. 438 (110th), H.R. 5629 (110th), S. 623 (110th), H.R. 1038 (110th)

Budget/Appropriations BUD

Agriculture Appropriations for FY 2009: FDA (OGD) Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

H.R. 1902 Protecting Consumers Access to Generic Drugs Act of 2007 S. 316 Preserve Access to Affordable Generics Act S. 1082 Prescription Drug User Fee Amendments of 2007 H.R. 2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S. 251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting /pedigree issues. Various bills and amendments relating to drug importation. The Food and Drug Administration Amendments Act of 2007 S. 1951 Fair Medicaid Drug Payment Act H.R. 3140 Saving our Community Pharmacies Act H.R. 3193 Access to Community Pharmacy Preservation Act Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 3193 (110th), S. 316 (110th), H.R. 1902 (110th), H.R. 3140 (110th), S. 1951 (110th), H.R. 2716 (110th), S. 1082 (110th), S. 251 (110th)

Medical/Disease Research/Clinical Labs MED

H.R. 3162 Children's Health and Medicare Protection Act S.1893 Children's Health Insurance Program Reauthorization Act of 2007 H.R. 1193/S.691 Kidney Care Quality and Education Act of 2007

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1893 (110th), S. 691 (110th), H.R. 3162 (110th), H.R. 1193 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.